Marine macrolides, a promising source fo anitumor compounds

Anti-Cancer Agents in Medicinal Chemistry

Volumn 9, Issue 2, 2009, Pages 122-137

  Napolitano, José G ^a   Daranas, Antonio H ^a   Norte, Manuel ^a   Fernández, José J ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Antitumor agents; Cancer; Cytotoxicity; Marine macrolides; Natural products

Indexed keywords

13 DEOXYTEDANOLIDE; ANTINEOPLASTIC AGENT; APLYRONINE A; BENZOLACTONE ENAMIDE; BRYOSTATIN 1; DICTYOSTATIN; DISCODERMOLIDE; HALICHONDRIN B; LATRUNCULIN A; LATRUNCULIN B; LAULIMALIDE; LOBATAMIDE C; MACROLIDE; MISAKINOLIDE; MYCALOLIDE A; MYCALOLIDE B; NATURAL PRODUCT; PACLITAXEL; PALMEROLIDE A; PATEAMINE A; PELORUSIDE A; PHORBOXAZOLE A; PHORBOXAZOLE B; REIDISPONGIOLIDE; SALICYLIHALAMIDE; SPHINXOLIDE; SPONGISTATIN 1; SPONGISTATIN 2; SWINHOLIDE A; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER RESEARCH; CANCER THERAPY; CLINICAL TRIAL; COLON CARCINOMA; CYTOSKELETON; DRUG ISOLATION; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; EHRLICH ASCITES TUMOR; HUMAN; LEWIS CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MARINE SPECIES; MELANOMA B16; MICROTUBULE ASSEMBLY; MURINE LEUKEMIA; NONHUMAN; REVIEW; STEREOCHEMISTRY; ANIMAL; CELL PROLIFERATION; CHEMISTRY; CONFORMATION; DRUG EFFECT; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MACROLIDES; MOLECULAR CONFORMATION;

EID: 64049084923     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152009787313800     Document Type: Review

References (224)

1. Harvey, A. Strategies for discovering drugs for previously unexplored natural products. Drug Discov. Today, 2000, 5, 294.
2. For recent reviews on marine natural products, see: Blunt, J.W.; Copp, B.R.; Hu, W.-P.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep., 2008, 25, 35.
3. Blunt, J.W.; Copp, B.R.; Hu, W.-P.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep., 2007, 24, 31.
4. Blunt, J.W.; Copp, B.R.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep., 2006, 23, 26.
5. Blunt, J.W.; Copp, B.R.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep., 2005, 22, 15.
6. Blunt, J.W.; Copp, B.R.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep., 2004, 21, 1.
7. Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod., 2003, 66, 1022.
8. For reviews on synthesis of marine natural products, see: Morris, J.C.; Phillips, A.J. Marine natural products: synthetic aspects. Nat. Prod. Rep., 2008, 25, 95.
9. Morris, J.C.; Nicholas, G.M.; Phillips, A.J. Marine natural products: synthetic aspects. Nat. Prod. Rep., 2007, 24, 87.
10. For recent reviews on pharmacological aspects of marine natural products, see: Banerjee, S.; Wang, Z.; Mohammad, M.; Sarkar, F.H.; Mohammad, R.M. Efficacy of selected natural products as therapeutic agents against cancer. J. Nat. Prod., 2008, 71, 492.
11. Nakao, Y.; Fusetani, N. Enzyme inhibitors from marine invertebrates. J. Nat. Prod., 2007, 70, 689.
12. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod., 2007, 70, 461.
13. Dixon, N.; Wong, L.S.; Geerlings, T.H.; Micklefield, J. Cellular targets of natural products. Nat. Prod. Rep., 2007, 24, 1288.
14. Baker, D.D.; Chu, M.; Oza, U.; Rajgarhia, V. The value of natural products to future pharmaceutical discovery. Nat. Prod. Rep., 2007, 24, 1225.
15. Mayer, A.M.S.; Gustafson, K.R. Marine pharmacology in 2003-2004: anti-tumour and cytotoxic compounds. Eur. J. Cancer, 2006, 42, 2241.
16. Drahl, C.; Cravatt, B.F; Sorensen, E.J. Protein-reactive natural products. Angew. Chem. Int. Ed., 2005, 44, 5788.
17. Butler, M.S. The role of natural product chemistry in drug discovery. J. Nat. Prod., 2004, 67, 2141.
18. Newman, D.J.; Cragg, G.M. Marine natural products and related compounds in clinical and advanced preclinical trials. J. Nat. Prod., 2004, 67, 1216.
19. Cragg, G.M.; Newman, D.J. A tale of two tumor targets: topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy. J. Nat. Prod., 2004, 67, 232.
20. Mayer, A.M.S.; Gustafson, K.R. Marine pharmacology in 2001-2: antitumour and cytotoxic compounds. Eur. J. Cancer, 2004, 40, 2676.
21. Rawlings, B.J. Biosynthesis of polyketides (other than actinomycete macrolides). Nat. Prod. Rep., 1999, 16, 425.
22. For recent reviews on synthesis of macrolides, see: Florence, G.J.; Gardner, N.M.; Paterson, I. Development of practical syntheses of the marine anticancer agents discodermolide and dictyostatin. Nat. Prod. Rep., 2008, 25, 342.
23. Yeung, K.-S.; Paterson, I. Advances in the total synthesis of biologically important marine macrolides. Chem. Rev., 2005, 105, 4237.
24. Yeung, K.-S.; Paterson, I. Actin-binding marine macrolides : total synthesis and biological importance. Angew. Chem. Int. Ed., 2002, 41, 4632.
25. Mutter, R.; Wills, M. Chemistry and clinical biology of the bryostatins. Bioorg. Med. Chem., 2000, 8, 1841.
26. Sudek, S.; Lopanik, N.B.; Waggoner, L.E.; Hildebrand, M.; Anderson, C.; Liu, H.; Patel, A.; Sherman, D.H.; Haygood, M.G. Identification of the putative bryostatin polyketide synthase gene cluster from " Candidatus endobugula sertula", the uncultivated microbial symbiont of the marine bryozoan Bugula neritina. J. Nat. Prod., 2007, 70, 67.
27. Kortmansky, J.; Schwartz, G.K. Bryostatin-1: a novel PKC inhibitor in clinical development. Cancer Investig., 2003, 21, 924.
28. Mohammad, R.M.; al-Katib, A.; Pettit, G.R.; Sensenbrenner, L.L. Successful treatment of human Waldenstrom's macroglobulinemia with combination biological and chemotherapy agents. Cancer Res., 1994, 54, 165.
29. Mohammad, R.M.; Varterasian, M.L.; Almatchy, V.P.; Hannoudi, G.N.; Pettit, G.R.; al-Katib, A. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1. Clin. Cancer Res., 1998, 4, 1337.
30. Mohammad, R.M.; Wall, N.R.; Dutcher, J.A.; al-Katib, A. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model. Clin. Cancer Res., 2000, 6, 4950.
31. Newman, D.J.; Cragg, G.M. In Natural Products: Drug Discovery and Therapeutic Medicine; Zhang, Demain, Eds.; Humana Press Inc.: Totowa, 2005; pp. 129-168. Ishibashi, M. In Macrolide Antibiotics: Chemistry, Biology and Practice, Second Edition; Omura, Ed.; Elsevier Science Inc.: San Diego, 2002; pp. 57-98.
32. Kobayashi, J.; Kubota, T. Bioactive macrolides and polyketides from marine dinoflagellates of the genus Amphidinium. J. Nat. Prod., 2007, 70, 451.
33. Kobayashi, J.; Tsuda, M. Amphidinolides, bioactive macrolides from symbiotic marine dinoflagellates. Nat. Prod. Rep., 2004, 21, 77.
34. Kobayashi, J.; Shimbo, K.; Kubota, T.; Tsuda, M. Bioactive macrolides and polyketides from marine dinoflagellates. Pure Appl. Chem., 2003, 75, 337.
35. Kashman, Y.; Groweiss, A.; Shmueli, U. Latrunculin, a new 2-thiazolidinone macrolide from the marine sponge Latrunculia magnifica. Tetrahedron Lett., 1980, 21, 3629.
36. Groweiss, A.; Shmueli, U.; Kashman, Y. Marine toxins of Latrunculia magnifica. J. Org. Chem., 1983, 48, 3512.
37. Jefford, C.W.; Bernardelli, G.; Tanaka, J.; Higa, T. Structures and absolute configurations of the marine toxins, latrunculin A and laulimalide. Tetrahedron Lett., 1996, 37, 159.
38. Spector, I.; Shochet, N.R.; Kashman, Y.; Groweiss, A. Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells. Science, 1983, 219, 493.
39. Coue, M.; Brenner, S.L.; Spector, I.; Korn, E.D. Inhibition of actin polymerization by latrunculin A. FEBS Lett., 1987, 213, 316.
40. Morton, W.M.; Ayscough, K.R.; McLaughlin, P.J. Latrunculin alters the actin-monomer subunit interface to prevent polymerization. Nat. Cell Biol., 2000, 2, 376.
41. Yarmola, E.G.; Somasundaram, T.; Boring, T.A.; Spector, I.; Bubb, M.R. Actin-latrunculin A structure and function. J. Biol. Chem., 2000, 275, 28120.
42. Gachet, Y.; Tournier, S.; Millar, J.B.A.; Hyams, J.S. A MAP kinase-dependent actin checkpoint ensures proper spindle orientation in fission yeast. Nature, 2001, 412, 352.
43. Roesener, J.A.; Scheuer, P.J. Ulapualide A and B, extraordinary antitumor macrolides from nudibranch eggmasses. J. Am. Chem. Soc., 1986, 108, 846.
44. Matsunaga, S.; Fusetani, N.; Hashimoto, K. Kabiramide C, a novel antifungal macrolide from nudibranch eggmasses. J. Am. Chem. Soc., 1986, 108, 847.
45. Matsunaga, S.; Fusetani, N.; Hashimoto, K.; Koseki, K.; Noma, M.; Noguchi, H.; Sankawa, U. Further kabiramides and halichondramides, cytotoxic macrolides embracing trisoxazole, from the Hexabranchus egg masses. J. Org. Chem., 1989, 54, 1360.
46. Fusetani, N.; Yasumuro, K.; Matsunaga, S.; Hashimoto, K. Mycalolides A-C, hybrid macrolides of ulapualides and halichondramide, from a sponge of the genus Mycale. Tetrahedron Lett., 1989, 30, 2809.
47. Rashid, M.A.; Gustafson, K.R.; Cardellina, II, J.H.; Boyd, M.R. Mycalolides D and E, new cytotoxic macrolides from a collection of the stony coral Tubastrea faulkneri. J. Nat. Prod., 1996, 58, 1120.
48. Kernan, M.R.; Faulkner, D.J. Halichondramide, an antifungal macrolide from the sponge Halichondria sp. Tetrahedron Lett., 1987, 28, 2809.
49. Kernan, M.R.; Molinski, T.F.; Faulkner, D.J. Macrocyclic antifungal metabolites from the spanish dancer nudibranch Hexabranchus sanguineus and sponges of the genus Halichondria. J. Org. Chem., 1988, 53, 5014.
50. Kobayashi, J.; Tsuda, M.; Fuse, H.; Sasaki, T.; Mikami, Y. Halishigamides A-D, new cytotoxic oxazole-containing metabolites from Okinawan sponge Halichondria sp. J. Nat. Prod., 1997, 60, 150.
51. Kobayashi, J.; Murata, O.; Shigemori, H. Jaspisamides A-C, new cytotoxic macrolides from the Okinawan sponge Jaspis sp. J. Nat. Prod., 1993, 56, 787.
52. Chattopadhyay, S.K.; Pattenden, G. Total synthesis of Ulapualide A, a novel tris-oxazole containing macrolide from the marine nudi-branch Hexabranchus sanguineus. Tetrahedron Lett., 1998, 39, 6095.
53. Chattopadhyay, S.K.; Pattenden, G. A total synthesis of the unique tris-oxazole macrolide ulapualide A produced by the marine nudibranch Hexabranchus sanguineus. J. Chem. Soc., Perkin Trans. 1, 2000, 2429.
54. Matsunaga, S.; Liu, P.; Celatka, C.A.; Panek, J.S.; Fusetani, N. Relative and absolute stereochemistry of mycalolides, bioactive macrolides from the marine sponge Mycale magellanica. J. Am. Chem. Soc., 1999, 121, 5605.
55. Liu, P.; Panek, J.S. Total synthesis of (-)-Mycalolide A. J. Am. Chem. Soc., 2000, 122, 1235.
56. Liu, P.; Panek, J.S. Total synthesis of the actin-depolymerizing agent (-)-mycalolide A: application of chiral silane-based bond construction methodology. J. Am. Chem. Soc., 2000, 122, 11090.
57. Hori, M.; Saito, S.; Shin, Y.; Ozaki, H.; Fusetani, N.; Karaki, H. Mycalolide-B, a novel and specific inhibitor of actomyosin ATPase isolated from marine sponge. FEBS Lett., 1993, 322, 151.
58. Saito, S.; Watabe, S.; Ozaki, H.; Fusetani, N.; Karaki, H. Mycalolide B, a novel actin depolymerizing agent. J. Biol. Chem., 1994, 269, 29710.
59. Klenchin, V.A.; Allingham, J.S.; King, R.; Tanaka, J.; Marriott, G.; Rayment, I. Trisoxazole macrolide toxins mimic the binding of actin-capping proteins to actin. Nat. Struct. Biol., 2003, 10, 1058.
60. Tanaka, J.; Yan, Y.; Choi, J.; Bai, J.; Klenchin, V.A.; Rayment, I.; Marriott, G. Biomolecular mimicry in the actin cytoskeleton: mechanisms underlying the cytotoxicity of kabiramide C and related macrolides. Proc. Natl. Acad. Sci. USA., 2003, 100, 13851.
61. Allingham, J.S.; Tanaka, J.; Marriott, G.; Rayment, I. Absolute stereochemistry of ulapualide A. Org. Lett., 2004, 6, 597.
62. Carmely, S.; Kashman, Y. Structure of swinholide A, a new macrolide from the marine sponge Theonella swinhoei. Tetrahedron Lett., 1985, 26, 511.
63. Kobayashi, M.; Tanaka, J.; Katori, T.; Matsuura, M.; Kitagawa, I. Structure of swinholide A, a potente cytotoxic macrolide from the Okinawan marine sponge Theonella swinhoei. Tetrahedron Lett., 1989, 30, 2963.
64. Kitagawa, I.; Kobayashi, M.; Katori, T.; Yamashita, M. Absolute stereostructure of swinholide A, a potent cytotoxic macrolide from the okinawan marine sponge Theonella swinhoei. J. Am. Chem. Soc., 1990, 112, 3710.
65. Doi, M.; Ishida, T.; Kobayashi, M.; Kitagawa, I. Molecular conformation of swinholide A, a potent cytotoxic dimeric macrolide from the Okinawan marine sponge Theonella swinhoei: X-ray crystal structure of its diketone derivative. J. Org. Chem., 1991, 56, 3629.
66. Paterson, I.; Yeung, K.-S.; Ward, R.A.; Cumming, J.G.; Smith, J.D. Total synthesis of swinholide A and hemiswinholide A. J. Am. Chem. Soc., 1994, 116, 9391.
67. Bubb, M.R.; Spector, I.; Bershadsky, A.D.; Korn, E.D. Swinholide A is a microfilament disrupting marine toxin that stabilizes actin dimers and severs actin filaments. J. Biol. Chem., 1995, 270, 3463.
68. Kato, Y.; Fusetani, N.; Matsunaga, S.; Hashimoto, K.; Sakai, R.; Higa, T.; Kashman, Y. Antitumor macrodiolides isolated from a marine sponge Theonella sp.: structure revision of misakinolide A. Tetrahedron Lett., 1987, 28, 6225.
69. Watabe, S.; Wada, S.; Saito, S.; Matsunaga, S.; Fusetani, N.; Ozaki, H.; Karaki, H. Cellular changes of rat embryonic fibroblasts by an actin-polymerization inhibitor, bistheonellide A, from a marine sponge. Cell Struct. Funct., 1996, 21, 199.
70. Terry, D.R.; Spector, I.; Higa, T.; Bubb, M.R. Misakinolide A is a marine macrolide that caps but does not sever filamentous actin. J. Biol. Chem., 1997, 272, 7841.
71. Klenchin, V.A.; King, R.; Tanaka, J.; Marriott, G.; Rayment, I. Structural basis of swinholide A binding to actin. Chem. Biol., 2005, 12, 287.
72. Guella, G.; Manzini, I.; Chiasera, G.; Pietra, F. Sphinxolide, a 26-membered antitumoral macrolide isolated from an unidentified Pacific nudibranch. Helv. Chim. Acta., 1989, 72, 237.
73. D'Auria, M.V.; Gomez-Paloma, L.; Minale, L.; Zampella, A.; Verbist, J.-F.; Roussakis, C.; Debitus, C. Three new potent cytotoxic macrolides closely related to sphinxolide from the New Caledonian sponge Neosiphonia superstes. Tetrahedron., 1993, 49, 8657.
74. D'Auria, M.V.; Gomez-Paloma, L.; Minale, L.; Zampella, A.; Verbist, J.-F.; Roussakis, C.; Debitus, C.; Patissou, J. Reidispongiolide A and B, two new potent cytotoxic macrolides from the New Caledonian sponge Reidispongia coerulea. Tetrahedron., 1994, 50, 4829.
75. Carbonelli, S.; Zampella, A.; Randazzo, A.; Debitus, C.; Gomez-Paloma, L. Sphinxolides E-G and reidispongiolide C: four new cytotoxic macrolides from the New Caledonian lithistida sponges N. superstes and R. coerulea. Tetrahedron, 1999, 55, 14665.
76. Bassarello, C.; Bifulco, G.; Zampella, A.; D'Auria, M.V.; Riccio, R.; Gomez-Paloma, L. Stereochemical studies on sphinxolide: advances in the J-Based NMR. Determination of the relative configuration of flexible systems. Eur. J. Org. Chem., 2001, 39.
77. Riccio, R.; Bifulco, G.; Cimino, P.; Bassarello, C.; Gomez-Paloma, L. Stereochemical analysis of natural products. Approaches relying on the combination of NMR spectroscopy and computational methods. Pure Appl. Chem., 2003, 75, 295.
78. Bifulco, G.; Bassarello, C.; Riccio, R.; Gomez-Paloma, L. Quantum mechanical calculations of NMR J coupling values in the determination of relative configuration in organic compounds. Org. Lett., 2004, 6, 1025.
79. Bifulco, G.; Dambrouso, P.; Gomez-Paloma, L.; Riccio, R. Determination of relative configuration in organic compounds by NMR spectroscopy and computational methods. Chem. Rev., 2007, 107, 3744.
80. Zhang, X.; Minale, L.; Zampella, A.; Smith, C.D. Microfilament depletion and circumvention of multiple drug resistance by sphinxolides. Cancer Res., 1997, 57, 3751.
81. Allingham, J.S.; Zampella, A.; D'Auria, M.V.; Rayment, I. Structures of microfilament destabilizing toxins bound to actin provide insight into toxin design and activity. Proc. Natl. Acad. Sci. USA., 2005, 102, 14527.
82. Paterson, I.; Ashton, K.; Britton, R.; Cecere, G.; Chouraqui, G.; Florence, G.J.; Stafford, J. Total synthesis of (-)-reidispongiolide A, an actin-targeting marine macrolide. Angew. Chem. Int. Ed., 2007, 46, 6167.
83. Yamada, K.; Ojika, M.; Ishigaki, T.; Yoshida, Y.; Ekimoto, H.; Arakawa, M. Aplyronine A, a potent antitumor substance, and the congeners aplyronines B and C isolated from the sea hare Aplysia kurodai. J. Am. Chem. Soc., 1993, 115, 11020.
84. Ojika, M.; Kigoshi, H.; Ishigaki, T.; Tsukuda, I.; Tsuboi, T.; Ogawa, T.; Yamada, K. Absolute stereochemistry of aplyronine A, a potent antitumor substance of marine origin. J. Am. Chem. Soc., 1994, 116, 7441.
85. Kigoshi, H.; Ojika, M.; Ishigaki, T.; Suenaga, K.; Mutou, T.; Sakakura, A.; Ogawa, T.; Yamada, K. Total synthesis of aplyronine A, a potent antitumor substance of marine origin. J. Am. Chem. Soc., 1994, 116, 7443.
86. Suenaga, K.; Ishigaki, T.; Sakakura, A.; Kigoshi, H.; Yamada, K. Absolute stereochemistry and synthesis of aplyronines B and C, the congeners of aplyronine A, a potent antitumor substance of marine origin. Tetrahedron Lett., 1995, 36, 5053.
87. Kigoshi, H.; Suenaga, K.; Mutou, T.; Ishigaki, T.; Atsumi, T.; Ishiwata, H.; Sakakura, A.; Ogawa, T.; Ojika, M.; Yamada, K. Aplyronine A, a potent antitumor substance of marine origin, aplyronines B and C, and artificial analogues: total synthesis and structure-cytotoxicity relationships. J. Org. Chem., 1996, 61, 5326.
88. Kigoshi, H.; Suenaga, K.; Takagi, M.; Akao, A.; Kanematsu, K.; Kamei, N.; Yamada, K. Cytotoxicity and actin-depolymerizing activity of aplyronine A, a potent antitumor macrolide of marine origin, and its analogs. Tetrahedron., 2002, 58, 1075.
89. Kuroda, T.; Suenaga, K.; Sakakura, A.; Handa, T.; Okamoto, K.; Kigoshi, H. Study of the interaction between actin and antitumor substance aplyronine A with a novel fluorescent photoaffinity probe. Bioconj. Chem., 2006, 17, 524.
90. Hirata, K.; Muraoka, S.; Suenaga, K.; Kuroda, T.; Kato, K.; Tanaka, H.; Yamamoto, M.; Takata, M.; Yamada, K.; Kigoshi, H. Structure basis for antitumor effect of aplyronine A. J. Mol. Biol., 2006, 356, 945.
91. Hirata, Y.; Uemura, D. Halichondrins - antitumor polyethers macrolides from a marine sponge. Pure Appl. Chem., 1986, 58, 701.
92. Uemura, D.; Takahashi, K.; Yamamoto, T.; Katayama, C.; Tanaka, J.; Okumura, Y.; Hirata, Y. Norhalichondrin A: an antitumor polyether macrolide from a marine sponge. J. Am. Chem. Soc., 1985, 107, 4796.
93. Pettit, G.R.; Herald, C.L.; Boyd, M.R.; Leet, J.E.; Dufresne, C.; Doubek, D.L.; Schmidt, J.M.; Cerny, R.L.; Hooper, J.N.; Rutzler, K.C. Antineoplastic agents 219. Isolation and structure of the cell growth inhibitory constituents from the Western Pacific marine sponge Axinella sp. J. Med. Chem., 1991, 34, 3339.
94. Pettit, G.R.; Tan, R.; Williams, M.D.; Doubek, D.L.; Boyd, M.R.; Schmidt, J.M.; Chapuis, J.-C.; Hamel, E.; Bai, R.; Hooper, J.N.; Tackett, L.P. Isolation and structure of halistatin 1 from the eastern Indian ocean marine sponge Phakellia carteri. J. Org. Chem., 1993, 58, 2538.
95. Litaudon, M.; Hart, J.B.; Blunt, J.W.; Lake, R.J.; Munro, M.H.G. Isohomohalichondrin B, a new antitumor polyether macrolide from the New Zealand deep water sponge Lissodendoryx sp. Tetrahedron Lett., 1994, 35, 9435.
96. Pettit, G.R.; Ichihara, Y.; Wurzel, G.; Williams, M.D.; Schmidt, J.M.; Chapuis, J.-C. Isolation and structure of halistatin 3 from the western Pacific (Chuuk) marine sponge Phakellia sp. J. Chem. Soc., Chem. Commun., 1995, 383.
97. Luduena, R.F.; Roach, M.C.; Prasad, V.; Pettit, G.R. Interaction of halichondrin B and homohalichondrin B with bovine brain tubulin. Biochem. Pharmacol., 1993, 45, 421.
98. Bai, R.L.; Paull, K.D.; Herald, C.L.; Malspeis, L.; Pettit, G.R.; Hamel, E. Halichondrin B and homohalichondrin B, marine natural product binding in the vinca domain of tubulin. J. Biol. Chem., 1991, 266, 15882.
99. Cooper, A.; Salomon, R. Total synthesis of halichondrins: enantioselective construction of a homochiral pentacyclic C1-C15 intermediate from D-ribose. Tetrahedron Lett., 1990, 31, 3813.
100. Aicher, T.D.; Buszek, K.R.; Fang, F.G.; Forsyth, C.J.; Jung, S.H.; Kishi, Y.; Scola, P.M.; Spero, D.M.; Yoon, S.K. Total synthesis of halichondrin B and norhalichondrin B. J. Am. Chem. Soc., 1992, 114, 3162.
101. Stamos, D.P.; Chen, S.S.; Kishi, Y.; New synthetic route to the C14-C38 segment of halichondrins. J. Org. Chem., 1997, 62, 7552.
102. Wang, Y.; Habgood, G.; Christ, W.; Littlefield, B.Y.; Melvin, J. Structure-activity studies of halichondrin B analogues: modifications at C30-C38. Bioorg. Med. Chem. Lett., 2000, 10, 1029.
103. Towle, M.J.; Salvato, K.A.; Budrow, J. In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B. Cancer Res., 2001, 61, 1013.
104. Namba, K.; Jun, H.-S.; Kishi, Y.; A simple but remarkably effective device for forming C8-C14 polycyclic ring system of halichondrin B. J. Am. Chem. Soc., 2004, 126, 7770.
105. Pettit, G.R.; Cichacz, Z.A.; Gao, F.; Herald, C.L.; Boyd, M.R.; Schmidt, J.M.; Hooper, J.N.A. Isolation and structure of spongistatin 1. J. Org. Chem., 1993, 58, 1302.
106. Fusetani, N.; Shinoda, K.; Matsunaga, S. Cinachyrolide A: a potent cytotoxic macrolide possessing two spiro ketals from marine sponge Cinachyra sp. J. Am. Chem. Soc., 1993, 115, 3977.
107. Kobayashi, M.; Aoki, S.; Sakai, H.; Kawazoe, K.; Kihara, N.; Sasaki, T.; Kitagawa, I. Altohyrtin A, a potent anti-tumor macrolide from the Okinawan marine sponge Hyrtios altum. Tetrahedron Lett., 1993, 34, 2795.
108. Kobayashi, M.; Aoki, S.; Sakai, H.; Kihara, N.; Sasaki, T.; Kitagawa, I. Altohyrtins B and C and 5-desacetylaltohyrtin A, potent cytotoxic macrolide congeners of altohyrtin A, from the Okinawan marine sponge Hyrtios altum. Chem. Pharm. Bull., 1993, 41, 989.
109. Kobayashi, M.; Aoki, S.; Gato, K.; Kitagawa, I. Marine natural products XXXVIII. Absolute stereostructures of altohyrtins A, B and C and 5-desacetylaltohyrtin A, potent cytotoxic macrolides, from the Okinawan marine sponge Hyrtios altum. Chem. Pharm. Bull., 1996, 44, 2142.
110. Evans, D.A.; Coleman, P.J.; Diaz, L.C. Enantioselective synthesis of altohyrtin C (spongistatin 2): synthesis of the AB- and CD-spiroketal subunits. Angew. Chem. Int. Ed., 1997, 36, 2737.
111. Guo, J.; Duffy, K.J.; Stevens, K.L.; Dalko, P.I.; Roth, R.M.; Wayward, M.M.; Kishi, Y. Total synthesis of altohyrtin A (spongistatin 1). Angew. Chem. Int. Ed., 1998, 37, 187.
112. Claffey, M.M.; Heathcock, C.H. A method for constructing the C2-C12 dispiroacetal moiety of altohyrtin A. J. Org. Chem., 1996, 61, 7646.
113. Paquette, L.A.; Zuey, D. A modular approach to marine macrolide construction 1. An enantiocontrolled route to the C1-C12 (AB) spiroacetal sector. Tetrahedron Lett., 1997, 38, 5115.
114. Paterson, I.; Oballa, R.M.; Norcross, R.D. Studies in marine macrolide synthesis. Stereocontrolled syntesis of the AB-spiroacetal subunit of spongistatin 1 (altohyrtin A). Tetrahedron Lett., 1996, 37, 8581.
115. Smith, III, A.B.; Zhuang, L.; Brook, C.S.; Boldi, A.M.; McBriar, M.D.; Hoser, W.H.; Murase, N.; Nakayama, K.; Verhoest, P.R.; Lin, Q. Spongistatin synthetic studies. 1. Construction of a C(29-48) subtarget. Tetrahedron Lett., 1997, 38, 8667.
116. Pietruszka, J. Spongistatins, cynachyrolides, or altohyrtins? marine macrolides in cancer therapy. Angew. Chem. Int. Ed., 1998, 37, 2629.
117. Pettit, G.R.; Cichacz, Z.A.; Gao, F.; Herald, C.L.; Boyd, M.R. Isolation and structure of the remarkable human cancer cell growth inhibitors spongistatins 2 and 3 from an eastern Indian ocean Spongia sp. J. Chem. Soc., Chem. Comunn., 1993, 1166.
118. Pettit, R.K.; McAllister, S.C.; Pettit, G.R.; Herald, C.L.; Johnson, J.M.; Cichacz, Z.A. A broad spectrum antifungal from the marine sponge Hyrtios erecta. Int. J. Antimicrob. Agents., 1998, 9, 147.
119. Uckun, F.M.; Mao, C.; Jan, S.-T.; Huang, H.; Vassilev, A.O.; Navara, C.S.; Narla, R.K. Spongistatins as tubulin targeting agents. Curr. Pharm. Des., 2001, 7, 1291.
120. Bai, R.; Taylor, G.F.; Cichacz, Z.A.; Herald, C.L.; Kepler, J.A.; Pettit, G.R.; Hamel, E. The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domain. Biochemistry, 1995, 34, 9714.
121. Pettit, G.R.; Chicacz, Z.A.; Gao, F.; Boyd, M.R.; Schmidt, J.M. Isolation and structure of the cancer cell growth inhibitor dictyostatin 1. J. Chem. Soc., Chem. Commun., 1994, 1111.
122. Isbruker, R.A.; Cummins, J.; Pomponi, S.A.; Longley, R.E.; Wright, A.E. Tubulin polymerizing activity of dictyostatin-1, a polyketide of marine sponge origin. Biochem. Pharmacol., 2003, 66, 75.
123. Paterson, I.; Britton, R.; Delgado, O.; Wright, A.E. Stereochemical determination of dictyostatin, a novel microtubule-stabilising macrolide from the marine sponge Corallistidae sp. Chem. Commun., 2004, 632.
124. Paterson, I.; Britton, R.; Delgado, O.; Meyer, A.; Poullennec, K.G. Total synthesis and configurational assignment of (-)-dictyostatin, a microtubule-stabilizing macrolide of marine sponge origin. Angew. Chem. Int. Ed., 2004, 43, 4629.
125. Shin, Y.; Fournier, J.-H.; Fukui, Y.; Brückner, A.M.; Curran, D.P. Total synthesis of (-)-dictyostatin: confirmation of relative and absolute configurations. Angew. Chem. Int. Ed., 2004, 43, 4634.
126. Madiraju, C.; Edler, M.C.; Hamel, E.; Raccor, B.S.; Balachandran, R.; Zhu, G.; Giuliano, K.A.; Vogt, A.; Shin, Y.; Fournier, J.-H.; Fukui, Y.; Brückner, A.M.; Curran, D.P.; Day, B.W. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin. Biochemistry, 2005, 44, 15053.
127. Raccor, B.S.; Vogt, A.; Sikorski, R.P.; Madiraju, C.; Balachandran, R.; Montgomery, K.; Shin, Y.; Fukui, Y.; Jung, W.-H.; Curran, D.P.; Day, B.W. Cell-based and biochemical structure-activity analyses of analogs of the microtubule stabilizer dictyostatin. Mol. Pharmacol., 2008, 73, 718.
128. Quiñoa, E.; Kakou, Y.; Crews, P. Fijianolides, polyketide heterocycles from a marine sponge. J. Org. Chem., 1988, 53, 3642.
129. Corley, D.G.; Herb, R.; Moore, R.E.; Scheuer, P.J.; Paul, V.J. Laulimalides: new potent cytotoxic macrolides from a marine sponge and a nudibranch predator. J. Org. Chem., 1988, 53, 3644.
130. Cutignano, A.; Bruno, I.; Bifulco, G.; Casapullo, A.; Debitus, C.; Gomez-Paloma, L.; Riccio, R. Dactylolide, a new cytotoxic macrolide from the Vanuatu sponge Dactylospongia sp. Eur. J. Org. Chem., 2001, 775.
131. For a recent review on synthesis of laulimalide and analogues, see: Mulzer, J.; Ohler, E. Microtubule-stabilizing marine metabolite laulimalide and its derivatives: synthetic approaches and antitumor activity. Chem. Rev., 2003, 103, 3753.
132. Mooberry, S.L.; Tien, G.; Hernandez, A.H.; Plubrukarn, A.; Davidson, B.S. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents. Cancer Res., 1999, 59, 653.
133. Pryor, D.; O'Brate, A.; Bilcer, G.; Díaz, J.F.; Wang, Y.; Wang, Y.; Kabaki, M.; Jung, M.K.; Andreu, J.M., Ghosh, A.K.; Giannakakou, P.; Hamel, E. The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity. Biochemistry, 2002, 41, 9109.
134. Gapud, E.J.; Ghosh, A.K.; Hamel, E. Laulimalide and paclitaxel: a comparison of their effect on tubulin assembly and their synergistic action when present simultaneously. Mol. Pharmacol., 2004, 66, 113.
135. Wender, P.A.; Hedge, S.G.; Hubbard, R.D.; Zhang, L.; Mooberry, S.L. Synthesis and biological evaluation of (-)-laulimalide analogues. Org. Lett., 2003, 5, 3507.
136. Mooberry, S.L.; Randall-Hlubek, D.A.; Leal, R.M.; Hedge, S.G.; Hubbard, R.D.; Zhang, L.; Wender, P.A. Microtubule-stabilizing agents based on designed laulimalide analogues. Proc. Natl. Acad. Sci. USA, 2004, 101, 8803.
137. West, L.M.; Northcote, P.T.; Battershill, C.N. Peloruside A: a potent cytotoxic macrolide isolated from the New Zealand marine sponge Mycale sp. J. Org. Chem., 2000, 65, 445.
138. Liao, X.; Wu, Y.; De Brabander, J.K. Total synthesis and absolute configuration of the novel microtubule-stabilizing agent peloruside A. Angew. Chem. Int. Ed., 2003, 42, 1648.
139. Hood, K.A.; Bäckström, B.T.; West, L.M.; Northcote, P.T.; Berridge, M.V.; Miller, J.H. The novel cytotoxic sponge metabolite peloruside A, structurally similar to spongistatin 1, has unique bioactivity independent of protein kinase C. Anticancer Drug Des., 2001, 16, 155.
140. Hood, K.A.; West, L.M.; Rouwé, B.; Northcote, P.T.; Berridge, M.V.; Wakefield, S.J.; Miller, J.H. Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule-stabilizing activity. Cancer Res., 2002, 62, 3356.
141. Gaitanos, T.N.; Buey, R.M.; Díaz, J.F.; Northcote, P.T.; Teesdale-Spittle, P.; Andreu, J.M.; Miller, J.H. Peloruside A does not bind to the taxoid site on β-tubulin and retains its activity in multidrug-resistant cell lines. Cancer Res., 2004, 64, 5063.
142. Pineda, O.; Farràs, J.; Maccari, L.; Manetti, F.; Botta, M.; Vilarrasa, J. Computational comparison of microtubule-stabilising agents laulimalide and peloruside with taxol and colchicine. Bioorg. Med. Chem. Lett., 2004, 14, 4825.
143. Jiménez-Barbero, J.; Canales, A.; Northcote, P.T.; Buey, R.M.; Andreu, J.M.; Díaz, J.F. NMR determination of the bioactive conformation of peloruside A bound to microtubules. J. Am. Chem. Soc., 2006, 128, 8757.
144. Huzil J.T.; Chik, J.K.; Slysz, G.W.; Freedman, H.; Tuszynski, J.; Taylor, R.E.; Sackett, D.L.; Schriemer, D.C. A unique mode of microtubule stabilization induced by peloruside A. J. Mol. Biol., 2008, 378, 1016.
145. Jin, M.; Taylor, R.E. Total synthesis of (+)-peloruside A. Org. Lett., 2005, 7, 1303.
146. Ghosh, A.K.; Xu, X.; Kim, J.-H.; Xu, C.-X. Enantioselective total synthesis of peloruside A: a potent microtubule stabilizer. Org. Lett., 2008, 10, 1001.
147. Searle, P.A.; Molinski, T.F. Phorboxazoles A and B: potent cytostatic macrolides from marine sponge Phorbas sp. J. Am. Chem. Soc., 1995, 117, 8126.
148. Molinski, T.F. Absolute configuration of phorboxazoles A and B from the marine sponge, Phorbas sp. 2. C43 and complete stereochemistry. Tetrahedron Lett., 1996, 37, 7879.
149. Searle, P.A.; Molinski, T.F. Absolute configuration of phorboxazoles A and B from the marine sponge Phorbas sp. 1. Macrolide and hemiketal rings. J. Am. Chem. Soc., 1996, 118, 9422.
150. Forsyth, C.J.; Ahmed, F.; Cink, R.D.; Lee, C.S. Total synthesis of phorboxazole A. J. Am. Chem. Soc., 1998, 120, 5597.
151. Smith, III, A.B.; Verhoest, P.R.; Minbiole, K.P.; Schelhaas, M. Total synthesis of (+)-phorboxazole A. J. Am. Chem. Soc., 2001, 123, 4834.
152. Gonzalez, M.A.; Pattenden, G. A convergent total synthesis of phorboxazole A. Angew. Chem. Int. Ed., 2003, 42, 1255.
153. Wang, B.; Forsyth, C.J. Stereoselective synthesis of the phorboxazole A macrolide by ring-closing metathesis. Org. Lett., 2006, 8, 5223.
154. Li, D.-R.; Zhang, D.-H.; Sun, C.-Y.; Zhang, J.-W.; Yang, L.; Chen, J.; Liu, B.; Su, C.; Zhou, W.-S.; Lin, G.-Q. Total synthesis of phorboxazole B. Chem. Eur. J., 2006, 12, 1185.
155. Lucas, B.S.; Gopalsamuthiram, V.; Burke, S.D. Total synthesis of phorboxazole B. Angew. Chem. Int. Ed., 2007, 46, 769.
156. Smith, III, A.B.; Razler, T.M.; Ciavarri, J.P.; Hirose, T.; Ishikawa, T.; Meis, R.M. A second-generation total synthesis of (+)-phorboxazole A. J. Org. Chem., 2008, 73, 1192.
157. Forsyth, C.J.; Ying, L.; Chen, J.; La Clair, J.J. Phorboxazole analogues induce association of cdk4 with extranuclear cytokeratin intermediate filaments. J. Am. Chem. Soc., 2006, 128, 3858.
158. Uckun, F.M.; Forsyth, C.J. Anticancer activity of synthetic analogues of the phorboxazoles. Bioorg. Med. Chem. Lett., 2001, 11, 1181.
159. Smith, III, A.B.; Razler, T.M.; Meis, R.M.; Pettit, G.R. Synthesis and biological evaluation of phorboxazole congeners leading to the discovery and preparative-scale synthesis of (+)-chlorophorboxazole a possessing picomolar human solid tumor cell growth inhibitory activity. J. Org. Chem., 2008, 73, 1201.
160. Wieczorek, H.; Brown, D.; Grinstein, S.; Ehrenfeld, J.; Harvey, W.R. Animal plasma membrane energization by proton-motive V-ATPases. Bioessays, 1999, 21, 637.
161. Torigoe, T.; Izumi, H.; Ishiguchi, H.; Uramoto, H.; Murakami, T.; Ise, O.; Yoshida, Y.; Tanabe, M.; Nomoto, M.; Itoh, H.; Kohno, K. Enhanced expression of the human vacuolar H+-ATPase c subunit gene (ATP6L) in response to anticancer agents. J. Biol. Chem., 2002, 277, 36534.
162. Lu, X.; Qin, W.; Li, J.; Tan, N.; Pan, D.; Zhang, H.; Xie, L.; Yao, G.; Shu, H.; Yao, M.; Wan, D.; Gu, J.; Yang, S. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Cancer Res., 2005, 65, 6843.
163. For recent reviews on vacuolar ATPase inhibitors, see: Beutler, J.A.; McKee, T.C. Novel marine and microbial natural product inhibitors of vacuolar ATPase. Curr. Med. Chem., 2003, 10, 787.
164. Yet, L. Chemistry and biology of salicylihalamide A and related compounds. Chem. Rev., 2003, 103, 4283.
165. Erickson, K.L.; Beutler, J.A.; Cardellina II, J.H.; Boyd, M.R. Salicylihalamides A and B, novel cytotoxic macrolides from the marine sponge Haliclona sp. J. Org. Chem., 1997, 62, 8188.
166. Galinis, D.L.; McKee, T.C.; Pannell, L.K.; Cardellina II, J.H.; Boyd, M.R. Lobatamides A and B, novel cytotoxic macrolides from the tunicate Aplidium lobatum. J. Org. Chem., 1997, 62, 8968.
167. McKee, T.C.; Galinis, D.L.; Pannell, L.K.; Cardellina II, J.H.; Laakso, J.; Ireland, C.M.; Murray, L.; Capon, R.J.; Boyd, M.R. The lobatamides, novel cytotoxic macrolides from southwestern pacific tunicates. J. Org. Chem., 1998, 63, 7805.
168. Boyd, M.R.; Farina C.; Belfiore, P.; Gagliardi, S.; Kim, J.-W.; Hayakawa, Y.; Beutler, J.A.; McKee, T.C.; Bowman, B.J.; Bowman, E.J. Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-ATPases. J. Pharmacol. Exp. Ther., 2001, 297, 114.
169. Huss, M.; Ingenhorst, G.; König, S.; Gaßel, M.; Dröse, S.; Zeeck, A.; Altendorf, K.; Wieczorek, H. Concanamycin A, the specific inhibitor of V-ATPases, binds to the Vo subunit c. J. Biol. Chem., 2002, 277, 40544.
170. Xie, X.-S.; Padron, D.; Liao, X.; Wang, J.; Roth, M.G.; De Brabander, J.K. Salicylihalamide A inhibits the V0 sector of the V-ATPase through a mechanism distinct from bafilomycin A1. J. Biol. Chem., 2004, 279, 19755.
171. Wu, Y.; Esser, L.; De Brabander, J.K. Revision of the absolute configuration of salicylihalamide A through asymmetric total syntesis. Angew. Chem. Int. Ed., 2000, 39, 4308.
172. Snider, B.B.; Song, F. Total synthesis of (-)-salicylihalamide A. Org. Lett., 2001, 3, 1817.
173. Labrecque, D.; Charron, S.; Rej, R.; Blais, C.; Lamothe, S. Enantioselective total synthesis of salicylihalamides A and B. Tetrahedron Lett., 2001, 42, 2645.
174. Wu, Y.; Seguil, O.R.; De Brabander, J.K. Synthesis and initial structure-activity relationships of modified salicylihalamides. Org. Lett., 2000, 2, 4241.
175. Lebreton, S.; Xie, X.-S.; Ferguson, D.; De Brabander, J.K. Ring-closing metathesis: a powerful tool for the synthesis of simplified salicylihalamide-based V-ATPase inhibitors. Tetrahedron, 2004, 60, 9635.
176. Herb, C.; Maier, M.E. A formal total synthesis of the salicylihalamides. J. Org. Chem., 2003, 68, 8129.
177. Herb, C.; Bayer, A.; Maier, M.E. Total synthesis of salicylihalamides A and B. Chem. Eur. J., 2004, 10, 5649.
178. Haack, T.; Haack, K.-L.; Diederich, W.E.; Blackman, B.; Roy, S.; Pusuluri, S.; Georg, G.I. Formal total syntheses of the (-)-salicylihalamides A and B from D-glucose and L-rhamnose. J. Org. Chem., 2005, 70, 7592.
179. Shen, R.; Lin, C.T.; Porco, Jr., J.A. Total synthesis and stereochemical assignment of the salicylate antitumor macrolide lobatamide C. J. Am. Chem. Soc., 2002, 124, 5650.
180. Shen, R.; Lin, C.T.; Bowman, E.J.; Bowman, B.J.; Porco, Jr., J.A. Synthesis and V-ATPase inhibition of simplified lobatamide analogues. Org. Lett., 2002, 4, 3103.
181. Cantrell, C.L.; Gustafson, K.R.; Cecere, M.R.; Lewis, K.P.; Boyd, M.R. Chondropsins A and B: novel tumor cell growth-inhibitory macrolide lactams from the marine sponge Chondropsis sp. J. Am. Chem. Soc., 2000, 122, 8825.
182. Rashid, M.A.; Gustafson, K.R.; Boyd, M.R. New chondropsin macrolide lactams from marine sponges in the genus Ircinia. Tetrahedron Lett., 2001, 42, 1623.
183. Rashid, M.A.; Cantrell, C.L.; Gustafson, K.R.; Boyd, M.R. Chondropsin D, a new 37-membered-ring macrolide lactam from the marine sponge Chondropsis species. J. Nat. Prod., 2001, 64, 1341.
184. Rashid, M.A.; Gustafson, K.R.; Crouch, R.C.; Groweiss, A.; Pannell, L.K.; Van, Q.N.; Boyd, M.R. Application of high-field NMR and cryogenic probe technologies in the structural elucidation of poecillastrin A, a new antitumor macrolide lactam from the sponge Poecillastra species. Org. Lett., 2002, 4, 3293.
185. Takemoto, D.; Takekawa, Y.; Van Soest, R.W.M.; Fusetani, N.; Matsunaga, S. Poecillastrin D: A new cytotoxin of the chondropsin class from marine sponge Jaspis serpentina. Biosci. Biotechnol. Biochem., 2007, 71, 2697.
186. Takada, K.; Choi, B.W.; Rashid, M.A.; Gamble, W.R.; Cardellina, II, J.H.; Van, Q.N.; Lloyd, J.R.; McMahon, J.B.; Gustafson, K.R. Structural assignment of poecillastrins B and C, macrolide lactams from the deep-water Caribbean sponge Poecillastra species. J. Nat. Prod., 2007, 70, 428.
187. Plaza, A.; Baker, H.L.; Bewley, C.A. Mirabilin, an antitumor macrolide lactam from the marine sponge Siliquariaspongia mirabilis. J. Nat. Prod., 2008, 71, 473.
188. Bowman, E.J.; Gustafson, K.R.; Bowman, B.J.; Boyd, M.R. Identification of a new chondropsin class of antitumor compound that selectively inhibits V-ATPases. J. Biol. Chem., 2003, 278, 44147.
189. Kobayashi, J.; Cheng, J.; Ohta, T.; Nakamura, H.; Nozoe, S.; Hirata, Y.; Ohizumi, Y.; Sasaki, T. Iejimalides A and B, novel 24-membered macrolides with potent antileukemic activity from the Okinawan tunicate Eudistoma cf. rigida. J. Org. Chem., 1988, 53, 6147.
190. Shimbo, K.; Tsuda, M.; Fukushi, E.; Kawabata, J.; Kobayashi, J. Dytesinins A and B, new clerodane-type diterpenes with a cyclopropane ring from the tunicate Cystodytes sp. Tetrahedron, 2000, 56, 7923.
191. Tsuda, M.; Nozawa, K.; Shimbo, K.; Ishiyama, H.; Fukushi, E.; Kawabata, J.; Kobayashi, J. Stereochemistry of iejimalide B. Tetrahedron Lett., 2003, 44, 1395.
192. Nozawa, K.; Tsuda, M.; Ishiyama, H.; Sasaki, T.; Tsuruo, T.; Kobayashi, J. Absolute stereochemistry and antitumor activity of iejimalides. Bioorg. Med. Chem., 2006, 14, 1063.
193. Fürstner, A.; Nevado, C.; Tremblay, M.; Chevrier, C.; Teply, F.; Aïssa, C.; Waser, M. Total synthesis of iejimalide B. Angew. Chem. Int. Ed., 2006, 45, 5837.
194. Fürstner, A.; Nevado, C.; Waser, M.; Tremblay, M.; Chevrier, C.; Teply, F.; Aïssa, C.; Moulin, E.; Müller, O. Total synthesis of iejimalide A-D and assessment of the remarkable actin-depolymerizing capacity of these polyene macrolides. J. Am. Chem. Soc., 2007, 129, 9150.
195. Kazami, S.; Muroi, M.; Kawatani, M.; Kubota, T.; Usui, T.; Kobayashi, J.; Osada, H. Iejimalides show anti-osteoclast activity via V-ATPase inhibition. Biosci. Biotechnol. Biochem., 2006, 70, 1364.
196. Schweitzer, D.; Zhu, J.; Jarori, G.; Tanaka, J.; Higa, T.; Davisson, V.J.; Helquist, P. Synthesis of carbamate derivatives of iejimalides. Retention of normal antiproliferative activity and localization of binding in cancer cells. Bioorg. Med. Chem., 2007, 15, 3208.
197. Diyabalange, T.; Amsler, C.D.; McClintock, J.B.; Baker, B.J. Palmerolide A, a cytotoxic macrolide from the antarctic tunicate Synoicum adareanum. J. Am. Chem. Soc., 2006, 128, 5630.
198. Lebar, M.D.; Baker, B.J. On the stereochemistry of palmerolide A. Tetrahedron Lett., 2007, 48, 8009.
199. Jiang, X.; Liu, B.; Lebreton, S.; De Brabander, J.K. Total synthesis and structure revision of the marine metabolite palmerolide A. J. Am. Chem. Soc., 2007, 129, 6386.
200. Nicolaou, K.C.; Guduru, R.; Sun, Y.-P.; Banerji, B.; Chen, D.Y.-K. Total synthesis of the originally proposed and revised structures of palmerolide A. Angew. Chem. Int. Ed., 2007, 46, 5896.
201. Nicolaou, K.C.; Sun, Y.-P.; Guduru, R.; Banerji, B.; Chen, D.Y.-K. Total synthesis of the originally proposed and revised structures of palmerolide A and isomers thereof. J. Am. Chem. Soc., 2008, 130, 3633.
202. Nicolaou, K.C.; Leung, G.Y.C.; Dethe, D.H.; Guduru, R.; Sun, Y.-P.; Lim, C.S.; Chen, D.Y.-K. Chemical synthesis and biological evaluation of palmerolide A analogues. J. Am. Chem. Soc., 2008, 130, 10019.
203. Northcote, P.T.; Blunt, J.W.; Munro, M.H.G. Pateamine: a potent cytotoxin from the New Zealand sponge, Mycale sp. Tetrahedron Lett., 1991, 32, 6411.
204. Hood, K.A.; West, L.M.; Northcote, P.T.; Berridge, M.V.; Miller, J.H. Induction of apoptosis by the marine sponge (Mycale) metabolites, mycalamide A and pateamine. Apoptosis, 2001, 6, 207.
205. Rzasa, R.M.; Shea, H.A.; Romo, D. Total synthesis of the novel, immunosuppressive agent (-)-pateamine A from Mycale sp. employing a β-lactam-based macrocyclization. J. Am. Chem. Soc., 1998, 120, 591.
206. Romo, D.; Rzasa, R.M.; Shea, H.A.; Park, K.; Langenhan, J.M.; Sun, L.; Akhiezer, A.; Liu, J.O. Total synthesis and immunosuppressive activity of (-)-pateamine A and related compounds: implementation of a β-lactam-based macrocyclization. J. Am. Chem. Soc., 1998, 120, 12237.
207. Romo, D.; Choi, N.S.; Li, S.; Buchler, I.; Shi, Z.; Liu, J.O. Evidence for separate binding and scaffolding domains in the immunosuppressive and antitumor marine natural product, pateamine A: design, synthesis, and activity studies leading to a potent simplified derivative. J. Am. Chem. Soc., 2004, 126, 10582.
208. Bordeleau, M.; Matthews, J.; Wojnar, J.M.; Lindqvist, L.; Novac, O.; Jankowsky, E.; Sonenberg, N.; Northcote, P.; Teesdale-Spittle, P.; Pelletier, J. Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation. Proc. Natl. Acad. Sci. USA., 2005, 102, 10460.
209. Low, W.-K.; Dang, Y.; Schneider-Poetsch, T.; Shi, Z.; Choi, N.-S.; Merrick, W.C.; Romo, D.; Liu, J.O. Inhibition of eukaryotic translation initiation by the marine natural product pateamine A. Mol. Cell., 2005, 20, 709.
210. Bordeleau, M.; Cencic, R.; Lindqvist, L.; Oberer, M.; Northcote, P.; Wagner, G.; Pelletier, J. RNA-mediated sequestration of the RNA helicase eIF4A by pateamine A inhibits translation initiation. Chem. Biol., 2006, 13, 1287.
211. Low, W.-K.; Dang, Y.; Schneider-Poetsch, T.; Shi, Z.; Choi, N.-S.; Rzasa, R.M.; Shea, H.A.; Li, S.; Park, K.; Ma, G.; Romo, D.; Liu, J.O. Isolation and identification of eukaryotic initiation factor 4A as a molecular target for the marine natural product pateamine A. Methods Enzymol., 2007, 431, 303.
212. Low, W.-K.; Dang, Y.; Bhat, S.; Romo, D.; Liu, J.O. Substrate-dependent targeting of eukaryotic translation initiation factor 4a by pateamine A: Negation of domain-linker regulation of activity. Chem. Biol., 2007, 14, 715.
213. Fusetani, N.; Sugawara, T.; Matsunaga, S. Cytotoxic metabolites of the marine sponge Mycale adhaerens Lambe. J. Org. Chem., 1991, 56, 4971.
214. Nishimura, S.; Matsunaga, S.; Yoshida, S.; Nakao, Y.; Yokoyama, S.; Fusetani, N. 13-Deoxytedanolide, a marine sponge-derived antitumor macrolide, binds to the 60S large ribosomal subunit. Bioorg. Med. Chem., 2005, 13, 449.
215. Schroeder, S.J.; Blaha, G.; Tirado-Rives, J.; Steitz, T.; Moore, P.B. The structures of antibiotics bound to the E site region of the 50 S ribosomal bubunit of Haloarcula marismortui: 13-deoxytedanolide and girodazole. J. Mol. Biol., 2007, 367, 1471.
216. Schmitz, F.J.; Gunasekera, S.P.; Yalamanchili, G.; Hossain, M.B.; Van der Helm, D. Tedanolide: A potent cytotoxic macrolide from the Caribbean sponge Tedania ignis. J. Am. Chem. Soc., 1984, 106, 7251.
217. Chevallier, C.; Bugni, T.S.; Feng, X.; Harper, M.K.; Orendt, A.M.; Ireland, C.M. Tedanolide C: A potent new 18-membered-ring cytotoxic macrolide isolated from the Papua New Guinea marine sponge Ircinia sp. J. Org. Chem., 2006, 71, 2510.
218. Meragelman, T.L.; Willis, R.H.; Woldemichael, G.M.; Heaton, A.; Murphy, P.T.; Snader, K.M.; Newman, D.J.; Van Soest, R.; Boyd, M.R.; Cardellina, II, J.H.; McKee, T.C. Candidaspongiolides, distinctive analogues of tedanolide from sponges of the genus Candidaspongia. J. Nat. Prod., 2007, 70, 1133.
219. Smith, III, A.B.; Adams, C.M.; Lodise Barbosa, S.A.; Degnan, A.P. Total synthesis of (+)-13-deoxytedanolide. J. Am. Chem. Soc., 2003, 125, 350.
220. Julian, L.D.; Newcom, J.S.; Roush, W.R. Total synthesis of (+)-13-deoxytedanolide. J. Am. Chem. Soc., 2005, 127, 6186.
221. Ehrlich, G.; Hassfeld, J.; Eggert, U.; Kalesse, M. The total synthesis of (+)-tedanolide. J. Am. Chem. Soc., 2006, 128, 14038.
222. Smith, III, A.B.; Lee, D. Total synthesis of (+)-tedanolide. J. Am. Chem. Soc., 2007, 129, 10957.
223. Ehrlich, G.; Hassfeld, J.; Eggert, U.; Kalesse, M. The total synthesis of (+)-tedanolide - A macrocyclic polyketide from marine sponge Tedania ignis. Chem. Eur. J., 2008, 14, 2232.
224. Nishimura, S.; Matsunaga, S.; Yoshida, S.; Nakao, Y.; Hirota, H.; Fusetani, N. Structure-activity relationship study on 13-deoxytedanolide, a highly antitumor macrolide from the marine sponge Mycale adhaerens. Bioorg. Med. Chem., 2005, 13, 455.